Anti-smooth muscle antibodies (ASMA) test is used to evaluate patients with a chronic hepatic disease who are suspected of having chronic active autoimmune hepatitis.
More information
Autoantibodies against smooth muscle (ASMA) tend to occur in patients with chronic active hepatitis and other liver-damaged diseases. The determination of these antibodies is used to diagnose primary biliary cirrhosis and chronic active autoimmune hepatitis. ASMA testing is usually performed in conjunction with antimitochondrial antibody (AMA) testing.
Possible Interpretations of Pathological Values
- Increase: Acute viral hepatitis, chronic active hepatitis, infectious mononucleosis, asthma, malignancies, primary biliary cirrhosis, viral infection
Important Note
Laboratory test results are the most critical parameter for diagnosing and monitoring all pathological conditions. Between 70 to 80% of diagnostic decisions are based on laboratory tests. Correctly interpreting laboratory results allows a doctor to distinguish "healthy" from "diseased."
Laboratory test results should not be interpreted from the numerical result of a single analysis. Test results should be analyzed based on each case and family history, clinical findings, and the results of other laboratory tests and information. Your physician should explain the importance of your test results.
At Diagnostiki Athinon, we answer any questions you may have about the test you perform in our laboratory and contact your doctor to ensure you receive the best possible medical care.
